Chapter/Section Purchase

1 Introduction to Research & Analysis Reports
1.1 Acute Myeloid Leukemia Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Acute Myeloid Leukemia Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Acute Myeloid Leukemia Overall Market Size
2.1 Global Acute Myeloid Leukemia Market Size: 2022 VS 2030
2.2 Global Acute Myeloid Leukemia Market Size, Prospects & Forecasts: 2018-2030
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Acute Myeloid Leukemia Players in Global Market
3.2 Top Global Acute Myeloid Leukemia Companies Ranked by Revenue
3.3 Global Acute Myeloid Leukemia Revenue by Companies
3.4 Top 3 and Top 5 Acute Myeloid Leukemia Companies in Global Market, by Revenue in 2022
3.5 Global Companies Acute Myeloid Leukemia Product Type
3.6 Tier 1, Tier 2 and Tier 3 Acute Myeloid Leukemia Players in Global Market
3.6.1 List of Global Tier 1 Acute Myeloid Leukemia Companies
3.6.2 List of Global Tier 2 and Tier 3 Acute Myeloid Leukemia Companies
4 Market Sights by Product
4.1 Overview
4.1.1 By Type - Global Acute Myeloid Leukemia Market Size Markets, 2022 & 2030
4.1.2 Chemotherapy
4.1.3 Targeted Therapy
4.2 By Type - Global Acute Myeloid Leukemia Revenue & Forecasts
4.2.1 By Type - Global Acute Myeloid Leukemia Revenue, 2018-2023
4.2.2 By Type - Global Acute Myeloid Leukemia Revenue, 2024-2030
4.2.3 By Type - Global Acute Myeloid Leukemia Revenue Market Share, 2018-2030
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Acute Myeloid Leukemia Market Size, 2022 & 2030
5.1.2 Adults
5.1.3 Children
5.2 By Application - Global Acute Myeloid Leukemia Revenue & Forecasts
5.2.1 By Application - Global Acute Myeloid Leukemia Revenue, 2018-2023
5.2.2 By Application - Global Acute Myeloid Leukemia Revenue, 2024-2030
5.2.3 By Application - Global Acute Myeloid Leukemia Revenue Market Share, 2018-2030
6 Sights by Region
6.1 By Region - Global Acute Myeloid Leukemia Market Size, 2022 & 2030
6.2 By Region - Global Acute Myeloid Leukemia Revenue & Forecasts
6.2.1 By Region - Global Acute Myeloid Leukemia Revenue, 2018-2023
6.2.2 By Region - Global Acute Myeloid Leukemia Revenue, 2024-2030
6.2.3 By Region - Global Acute Myeloid Leukemia Revenue Market Share, 2018-2030
6.3 North America
6.3.1 By Country - North America Acute Myeloid Leukemia Revenue, 2018-2030
6.3.2 US Acute Myeloid Leukemia Market Size, 2018-2030
6.3.3 Canada Acute Myeloid Leukemia Market Size, 2018-2030
6.3.4 Mexico Acute Myeloid Leukemia Market Size, 2018-2030
6.4 Europe
6.4.1 By Country - Europe Acute Myeloid Leukemia Revenue, 2018-2030
6.4.2 Germany Acute Myeloid Leukemia Market Size, 2018-2030
6.4.3 France Acute Myeloid Leukemia Market Size, 2018-2030
6.4.4 U.K. Acute Myeloid Leukemia Market Size, 2018-2030
6.4.5 Italy Acute Myeloid Leukemia Market Size, 2018-2030
6.4.6 Russia Acute Myeloid Leukemia Market Size, 2018-2030
6.4.7 Nordic Countries Acute Myeloid Leukemia Market Size, 2018-2030
6.4.8 Benelux Acute Myeloid Leukemia Market Size, 2018-2030
6.5 Asia
6.5.1 By Region - Asia Acute Myeloid Leukemia Revenue, 2018-2030
6.5.2 China Acute Myeloid Leukemia Market Size, 2018-2030
6.5.3 Japan Acute Myeloid Leukemia Market Size, 2018-2030
6.5.4 South Korea Acute Myeloid Leukemia Market Size, 2018-2030
6.5.5 Southeast Asia Acute Myeloid Leukemia Market Size, 2018-2030
6.5.6 India Acute Myeloid Leukemia Market Size, 2018-2030
6.6 South America
6.6.1 By Country - South America Acute Myeloid Leukemia Revenue, 2018-2030
6.6.2 Brazil Acute Myeloid Leukemia Market Size, 2018-2030
6.6.3 Argentina Acute Myeloid Leukemia Market Size, 2018-2030
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Acute Myeloid Leukemia Revenue, 2018-2030
6.7.2 Turkey Acute Myeloid Leukemia Market Size, 2018-2030
6.7.3 Israel Acute Myeloid Leukemia Market Size, 2018-2030
6.7.4 Saudi Arabia Acute Myeloid Leukemia Market Size, 2018-2030
6.7.5 UAE Acute Myeloid Leukemia Market Size, 2018-2030
7 Acute Myeloid Leukemia Companies Profiles
7.1 GSK
7.1.1 GSK Company Summary
7.1.2 GSK Business Overview
7.1.3 GSK Acute Myeloid Leukemia Major Product Offerings
7.1.4 GSK Acute Myeloid Leukemia Revenue in Global Market (2018-2023)
7.1.5 GSK Key News & Latest Developments
7.2 Novartis
7.2.1 Novartis Company Summary
7.2.2 Novartis Business Overview
7.2.3 Novartis Acute Myeloid Leukemia Major Product Offerings
7.2.4 Novartis Acute Myeloid Leukemia Revenue in Global Market (2018-2023)
7.2.5 Novartis Key News & Latest Developments
7.3 Roche
7.3.1 Roche Company Summary
7.3.2 Roche Business Overview
7.3.3 Roche Acute Myeloid Leukemia Major Product Offerings
7.3.4 Roche Acute Myeloid Leukemia Revenue in Global Market (2018-2023)
7.3.5 Roche Key News & Latest Developments
7.4 Bristol-Myers Squibb
7.4.1 Bristol-Myers Squibb Company Summary
7.4.2 Bristol-Myers Squibb Business Overview
7.4.3 Bristol-Myers Squibb Acute Myeloid Leukemia Major Product Offerings
7.4.4 Bristol-Myers Squibb Acute Myeloid Leukemia Revenue in Global Market (2018-2023)
7.4.5 Bristol-Myers Squibb Key News & Latest Developments
7.5 Celgene
7.5.1 Celgene Company Summary
7.5.2 Celgene Business Overview
7.5.3 Celgene Acute Myeloid Leukemia Major Product Offerings
7.5.4 Celgene Acute Myeloid Leukemia Revenue in Global Market (2018-2023)
7.5.5 Celgene Key News & Latest Developments
7.6 Clavis Pharma ASA
7.6.1 Clavis Pharma ASA Company Summary
7.6.2 Clavis Pharma ASA Business Overview
7.6.3 Clavis Pharma ASA Acute Myeloid Leukemia Major Product Offerings
7.6.4 Clavis Pharma ASA Acute Myeloid Leukemia Revenue in Global Market (2018-2023)
7.6.5 Clavis Pharma ASA Key News & Latest Developments
7.7 Daiichi Sankyo
7.7.1 Daiichi Sankyo Company Summary
7.7.2 Daiichi Sankyo Business Overview
7.7.3 Daiichi Sankyo Acute Myeloid Leukemia Major Product Offerings
7.7.4 Daiichi Sankyo Acute Myeloid Leukemia Revenue in Global Market (2018-2023)
7.7.5 Daiichi Sankyo Key News & Latest Developments
7.8 Eisai
7.8.1 Eisai Company Summary
7.8.2 Eisai Business Overview
7.8.3 Eisai Acute Myeloid Leukemia Major Product Offerings
7.8.4 Eisai Acute Myeloid Leukemia Revenue in Global Market (2018-2023)
7.8.5 Eisai Key News & Latest Developments
7.9 Teva
7.9.1 Teva Company Summary
7.9.2 Teva Business Overview
7.9.3 Teva Acute Myeloid Leukemia Major Product Offerings
7.9.4 Teva Acute Myeloid Leukemia Revenue in Global Market (2018-2023)
7.9.5 Teva Key News & Latest Developments
7.10 Sunesis Pharmaceuticals
7.10.1 Sunesis Pharmaceuticals Company Summary
7.10.2 Sunesis Pharmaceuticals Business Overview
7.10.3 Sunesis Pharmaceuticals Acute Myeloid Leukemia Major Product Offerings
7.10.4 Sunesis Pharmaceuticals Acute Myeloid Leukemia Revenue in Global Market (2018-2023)
7.10.5 Sunesis Pharmaceuticals Key News & Latest Developments
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer